Answers are grounded in this paper and cite their sources.
The Hoosier Oncology Group evaluated cimetidine in 42 patients with metastatic renal cell carcinoma. There were two complete remissions that lasted for 26 and 33+ months in 38 evaluable patients. There were no partial remissions. Toxicity was minimal. Patients with renal cell carcinoma can occasionally respond to cimetidine with long-term remission.
No takes yet. Share an insight, caveat, or question.
Inborn et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: